Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases

Surgery

Volumn 126, Issue 5, 1999, Pages 869-880

  Maurer, Christoph A ^a   Graber, Hans U ^a   Friess, Helmut ^a   Beyermann, Beate ^a   Willi, Doris ^a   Netzer, Peter ^a   Zimmermann, Arthur ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; MESSENGER RNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS; TUMOR SUPPRESSOR GENE;

EID: 0032693615     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(99)70028-0     Document Type: Article

References (32)

1. 1. MacFarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal cancer. Lancet 1993;341:457-60.
2. 2. Schalken JA, Ebeling SB, Issacs JT, Treiger B, Bussemakers MJG, de Jong MEM, Van de Ven WJM. Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Cancer Res 1988;48:2042-6.
3. 3. Dong JT, Lamb PW, Rinker-Schaeffer CW, Vukanovic J, Ichikawa T, Isaacs JT, Barrett JC. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-6.
4. 4. Nancy NJ. Marker genes face long road to the clinic. J Natl Cancer Inst 1995;87:1281-3.
5. 5. Ramshaw IA, Carlsen S, Wang HC, Badenoch-Jones P. The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer 1983;32:471-6.
6. 6. Ichikawa T, Ichikawa Y, Isaacs JT. Genetic factors and suppression of metastatic ability of prostatic cancer. Cancer Res 1991;51:3788-92.
7. 7. Wei LL, Yang X, Philips K, Weissman BE, Welch DR. Analysis of KAI-1 mRNA expression in human breast cancer cell lines. Proc Am Assoc Cancer Res 1996;37:76-83.
8. 8. Adachi M, Taki T, Ieki Y, Huang CI, Higashiyama M, Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res 1996;56:1751-5.
9. 9. Guo X, Friess H, Graber HU, Kashiwagi M, Zimmermann A, Korc M, Büchler MW. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 1996;56:4876-80.
10. 10. Hermanek P, Sobin LH. TNM classification of malignant tumors. 4th ed. Union International Contre Cancer, Geneva, New York: Springer; 1992.
11. 11. Müller CF, Fatzer R, Beck K, Vandevelde M, Zurbriggen A. Studies on canine distemper virus persistence in the control nervous system. Acta Neuropathol 1995;89:438-55.
12. 12. Cox KH, Deleon DV, Augerer LM, Augerer RC. Detection of mRNAs in sea urchin embryos by in situ hybridization using asymmetric RNA probes. Dev Biol 1984;101:485-502.
13. 13. Maurer CA, Friess H, Kretschmann B, Zimmermann A, Stauffer A, Baer HU, et al. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 1998;29:771-7.
14. 14. Maurer CA, Friess H, Kretschmann B, Wildi S, Muller C, Graber H, et al. Over-expression of ICAM-1, VCAM-1 and ELAM-1 might influence tumor progression in colorectal cancer. Int J Cancer 1998;79:76-81.
15. 15. Graber HU, Müller CF, Vandevelde M. Restricted infection with canine distemper virus leads to down regulation of myelin gene transcription in cultured oligodendrocytes. Acta Neuropathol 1995;90:1352-60.
16. 16. Sakar SN, Ghosh N. Reversible unfolding of escherichia coli alkaline phosphatase: active site can be reconstituted by a number of pathways. Arch Biochem Biophys 1996;330:174-80.
17. 17. Graber HU, Martig J. Urinary protein analysis in cardiomyopathy-affected and healthy cattle by sds-polyacrylamide gel electrophoresis. J Vet Med 1992;39:769-76.
18. 18. Lottaz D, Maurer CA, Hahn D, Buchler MW, Sterchi EE. Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteolytic potential in the stroma. Cancer Res 1999;59:1127-33.
19. 19. Maurer CA, Friess H, Buhler SS, Wahl BR, Graber H, Zimmermann A, Buchler MW. Apoptosis inhibiting factor Bcl-xL might be the crucial member of the Bcl-2 gene family in colorectal cancer. Dig Dis Sci 1998;43:2641-8.
20. 20. Maecker HT, Todd SC, Levy S. The tetraspanin superfarmily: molecular facilitators. FASEB J 1997;11:397-407.
21. 21. Wright MD, Tomlinson MG. The ins and outs of the transmemhrane 4 superfamily. Immunology Today 1994;15:588-95.
22. 22. Gaugitsch HW, Hofer E, Huber NE, Schnabal E, Baumruker T. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23. Eur J Immunol 1991;21:377-83.
23. 23. Gil ML, Vita N, Lebel-Binay S, Miloux B, Chalon P, Kaghad M, et al. A member of the tetraspanin transmembrane protein superfamily is recognized by a monoclonal antibody raised against an HLA class I-deficient, lymphokine-activated killer-susceptible, B lymphocyte line. J Immunol 1992;148:2826-33.
24. 24. Imai T, Fukudome K, Takagi S, Nagira M, Furuse M, Fukuhara N, et al. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J Immunol 1992;149:2879-86.
25. 25. Takaoka A, Hinoda Y, Satoh S, Adachi Y, Itoh F, Adachi M, Imai K. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene. Oncogene 1998;16: 1443-53.
26. 26. Miyake M, Koyama M, Seno M, Ikeyama S. Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility. J Exp Med 1991;174:1347-54.
27. 27. Si Z, Hersey P. Expression of the neuroglandular antigen and analogues in melanoma: CD9 expression appears inversely related to metastatic potential of melanoma. Int J Cancer 1993;54:37-43.
28. 28. Miyake M, Nakano K, Itoi SI, Koh T, Taki T. Motility-related protein-1 (MRP-1/CD9) reduction as a factor of poor prognosis in breast cancer. Cancer Res 1996;56:1244-9.
29. 29. Hotta H, Ross AH, Huebner K, Isobe M, Wendeborn S, Chao MV, et al. Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res 1988;48:2955-62.
30. 30. Nakamori S, Ishikawa O, Ohigashi H, Kameyama M, Furukawa H, Sasaki Y, et al. Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 1993;11:151-8.
31. 31. Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyaki M. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993;177:1231-7.
32. 32. Atkinson B, Ernst CS, Ghrist BF, Herlyn M, Blaszczyk M, Ross AH, et al. Identification of melanoma-associated antigens using fixed tissue screening of antibodies. Cancer Res 1984;44:2577-81.